Monte Rosa Therapeutics, Inc. Common Stock (GLUE) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for GLUE. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 185 institutions reported holding GLUE, with 92.7 million shares worth $2.2 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price | 8,861,171 | $214M | INCREASED |
| Nea Management Company | 7,692,298 | $186M | UNCHANGED |
| BlackRock | 6,843,087 | $166M | INCREASED |
| Vanguard | 4,791,577 | $116M | INCREASED |
| Tcg Crossover Management | 4,622,151 | $112M | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for Monte Rosa Therapeutics, Inc. Common Stock on SentiSense.